» Articles » PMID: 9336467

Convergence of TNFalpha and IFNgamma Signalling Pathways Through Synergistic Induction of IRF-1/ISGF-2 is Mediated by a Composite GAS/kappaB Promoter Element

Overview
Specialty Biochemistry
Date 1997 Oct 23
PMID 9336467
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular basis for the well known synergistic biological effects of tumor necrosis factor alpha (TNFalpha) and interferon gamma (IFNgamma) is still poorly understood. This report demonstrates that expression of interferon-regulatory factor 1 (IRF-1), also known as interferon-stimulated-gene factor 2 (ISGF-2), is synergistically induced by these cytokines. The induction is a primary transcriptional response that occurs rapidly without a requirement for new protein synthesis. Synergism is mediated by a novel composite element in the IRF-1 promoter that includes an IFNgamma-activation site (GAS) overlapped by a non-consensus site for nuclear factor kappa B (NFkappaB). These sequences are bound strongly by signal transducer and activator of transcription 1 (STAT-1) and weakly by the p50/p65 heterodimer form of NFkappaB, respectively. However, the binding of STAT-1 and NFkappaB to the GAS/kappaB element in vitro seems to be mutually exclusive and independent. Synergistic induction of IRF-1 is likely to be an important early step in regulatory networks critical to the synergism of TNFalpha and IFNgamma. The GAS/kappaB element may mediate synergistic transcriptional induction of IRF-1 by other pairs of ligands that together activate NFkappaB and STAT family members. Other genes are likely to contain this motif and be regulated similarly.

Citing Articles

A pairwise cytokine code explains the organism-wide response to sepsis.

Takahama M, Patil A, Richey G, Cipurko D, Johnson K, Carbonetto P Nat Immunol. 2024; 25(2):226-239.

PMID: 38191855 PMC: 10834370. DOI: 10.1038/s41590-023-01722-8.


The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment.

Huang X, Zhang F, Wang X, Liu K Cancers (Basel). 2022; 14(11).

PMID: 35681736 PMC: 9179436. DOI: 10.3390/cancers14112756.


Synergistic effect of IFN-γ and IL-1β on PD-L1 expression in hepatocellular carcinoma.

Numata Y, Akutsu N, Ishigami K, Koide H, Wagatsuma K, Motoya M Biochem Biophys Rep. 2022; 30:101270.

PMID: 35573813 PMC: 9095738. DOI: 10.1016/j.bbrep.2022.101270.


Regulatory Networks Involving STATs, IRFs, and NFκB in Inflammation.

Platanitis E, Decker T Front Immunol. 2018; 9:2542.

PMID: 30483250 PMC: 6242948. DOI: 10.3389/fimmu.2018.02542.


Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs.

Plens-Galaska M, Szelag M, Collado A, Marques P, Vallejo S, Ramos-Gonzalez M Front Immunol. 2018; 9:2141.

PMID: 30283459 PMC: 6156247. DOI: 10.3389/fimmu.2018.02141.


References
1.
Xu X, Sun Y, Hoey T . Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science. 1996; 273(5276):794-7. DOI: 10.1126/science.273.5276.794. View

2.
Aggarwal B, Natarajan K . Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw. 1996; 7(2):93-124. View

3.
Liu Z, Hsu H, Goeddel D, Karin M . Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell. 1996; 87(3):565-76. DOI: 10.1016/s0092-8674(00)81375-6. View

4.
Wilde C, Crowther C, Cripe T, Cowan N . Evidence that a human beta-tubulin pseudogene is derived from its corresponding mRNA. Nature. 1982; 297(5861):83-4. DOI: 10.1038/297083a0. View

5.
Larner A, Jonak G, Cheng Y, Korant B, Knight E, Darnell Jr J . Transcriptional induction of two genes in human cells by beta interferon. Proc Natl Acad Sci U S A. 1984; 81(21):6733-7. PMC: 392005. DOI: 10.1073/pnas.81.21.6733. View